UK researchers are exploring a revolutionary 'microdosing' strategy for powerful weight-loss medications like Wegovy, potentially slashing costs and side effects while boosting accessibility for NHS patients.
Exclusive investigation reveals the UK towns drowning in fast food, with Jaywick, Essex, crowned the nation's takeaway capital. Health experts sound the alarm on obesity crisis.
Exclusive investigation reveals the staggering postcode lottery and soaring costs of life-changing obesity drugs like Mounjaro and Wegovy, as the NHS struggles to cope with unprecedented demand.
Groundbreaking UK study reveals a new diabetes medication, Mounjaro (tirzepatide), achieves significantly greater weight loss and superior cardiovascular benefits compared to Ozempic, revolutionising obesity treatment.
A UK man's life was saved after he lost a staggering 38 stone and completely reversed his Type 2 diabetes through a groundbreaking NHS programme. Discover his inspiring transformation.
Former Culture Minister Ed Vaizey calls for VAT removal on prescription obesity drugs, arguing it would boost public health and reduce long-term NHS costs.
Ex-Culture Minister Ed Vaizey urges the NHS to widely prescribe revolutionary weight loss injections, calling them a potential 'miracle' for public health and a solution to the obesity crisis.
Exclusive: Medical experts warn of a deepening postcode lottery and a surge in the illegal black market for weight-loss jabs as NHS England struggles with supply and soaring demand for GLP-1 drugs.
Groundbreaking UK research finds semaglutide-based drugs, popular for weight loss, significantly improve symptoms and physical limitations in obese heart failure patients, offering a new potential treatment avenue.
Eli Lilly drastically cuts the price of its Mounjaro injection in the UK, making the revolutionary diabetes and weight loss treatment more accessible. The move follows a landmark NHS supply deal.
The UK's medicines watchdog approves the weight loss injection Mounjaro (tirzepatide), offering a powerful new option in the fight against obesity. Discover its price, how it works, and where to get it.
Eli Lilly suspends shipments of obesity drug Mounjaro to the UK, triggering a major price surge and leaving thousands of patients in limbo amid supply chain restructuring.
NHS England deploys a unique team of 'people experts' to hospitals in South London to manage severe winter pressures, patient flow, and staff welfare during a major incident.
Exclusive analysis reveals a dramatic surge in Britons turning to private medical care, driven by unprecedented NHS waiting times and a perceived 'postcode lottery' for treatment. This investigation uncovers the human cost of the healthcare crisis.
Exclusive NHS data reveals a shocking rise in children as young as ten being prescribed anti-obesity injections like Wegovy, raising serious safety concerns among medical experts.
Exclusive investigation reveals a record number of young children, some just three years old, are being referred to specialist obesity services amid a growing national health emergency.
Exclusive investigation reveals NHS splurged millions on PR and communications staff while GP practices struggle with funding shortages and patient backlogs.
The soaring cost of revolutionary new obesity drugs like Wegovy could force the NHS into a stark choice: ration treatments or find billions in new funding. This investigation reveals the immense financial pressure facing the health service.
A British woman's life-changing weight loss journey using Mounjaro injections has been thrown into turmoil after a dramatic price increase made the drug unaffordable, forcing her to confront the return of debilitating 'food noise'.
Scotland's NHS is spending a staggering £10 million annually on weight-loss injections like Ozempic and Wegovy as the nation battles a severe obesity epidemic. This investigative report reveals the soaring prescription costs and the pressing health challe
A mother's shocking journey from a dangerous 500-calorie diet to a life-saving NHS health transformation. Discover how she lost 5 stone and reclaimed her health.
Exclusive: A dramatic price war has broken out for 'game-changer' weight loss drugs Wegovy and Mounjaro in the UK, making them more accessible through private providers but raising concerns for the NHS.
A British mother who lost seven stone on diabetes drug Mounjaro issues urgent health warning after suffering severe side effects including vomiting brown liquid and excruciating stomach pain.
The NHS is spearheading a major crackdown on sugar and salt in baby food. Discover how new mandatory limits and a ban on sweeteners aim to reshape children's health and combat the UK's obesity crisis from weaning age.
A damning new report reveals UK supermarkets are making healthy food up to twice as expensive as unhealthy alternatives through aggressive promotions, disproportionately harming low-income families.
Groundbreaking research suggests popular weight loss injections like Wegovy and Ozempic could significantly lower the risk of obesity-related cancers, offering a potential double benefit for millions.
The NHS launches its most significant diabetes care reform in a decade, offering Ozempic-style injections to thousands in a bid to tackle obesity-driven type 2 cases and potentially slash future complications.
Exclusive analysis reveals NHS Scotland's staff sickness rates have soared to their highest level in 10 years, with 18 out of 18 health boards reporting increased absenteeism, raising alarm about workforce burnout and patient care.
New research suggests that popular weight loss injections may lead to rebound weight gain, raising concerns among health professionals.
Scotland's NHS introduces a groundbreaking soup and shake diet programme to combat diabetes and obesity, offering hope for thousands.